Finding and attribution
A user with fee-sheet ACL access can manipulate a submitted sale ID to read, alter, or delete drug-sale records for other patients; the save path does not check patient or encounter ownership.
Product: OpenEMR. AI system: AISLE AI analyzer (specific model/version not disclosed). Team / organization: AISLE.
CVE identifiers: CVE-2026-32120.
AI and human contribution (source account): AISLE’s April 28, 2026 article individually lists CVE-2026-32120 and states all listed issues were discovered using its AI analyzer. The OpenEMR primary advisory documents the specific defect and credits its finder. The model and human/AI work split are not specified.
Human involvement is only described where the source account establishes it; unknown involvement does not mean none. Vendor confirmation of a flaw does not confirm every claim about AI contribution.
Discovery context: OpenEMR published its advisory on 2026-03-25; AISLE publicly attributed its itemized findings to its AI analyzer on April 28, 2026. No exploitation-in-the-wild claim is made.
Remediation status: fix documented. OpenEMR lists 8.0.0.3 as a patched release. Deployment status is not assessed.
A source-documented fix does not establish installed patches or current safety. Source checking does not independently reproduce the finding or establish observed exploitation.
Disclosed 25 Mar 2026. AI attribution dated 28 Apr 2026. Sources checked 15 Nov 2026; these are separate dates, not a live installation check.
Recorded CVSS: Medium · highest recorded score 6.5. Documented technical effects: data disclosure, data modification.
Severity, consequences and exploitation evidence
Case grouping uses the highest recorded CVSS score, with its version-specific severity band. It is descriptive, not a combined or editorial risk index. All recorded assessments remain below; scores from different versions and sources may disagree. CVSS specifications define version-specific scoring and severity bands.
- CVE-2026-32120: CVSS 3.1 · 6.5 (Medium) ·
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N. GitHub_M (CNA; CVE Program record) · checked 16 Nov 2026.
CVE-2026-32120: data disclosure, data modification.
Prerequisites / affected scope: Any authenticated user with fee-sheet ACL can read, delete or modify drug_sales rows for arbitrary patients by manipulating sale_id..
Exploitation evidence: The cited source does not establish exploitation in the wild.. Impact source · checked 16 Nov 2026.
Documented fix: OpenEMR lists 8.0.0.3 as a patched release. Deployment status is not assessed.